Patent · US Active

Use of pegylated IL-10 to treat cancer

US9833514B2 · kind B2 · utility

1Cited by

15References

8Claims

0Family size

Assignee

Merck Sharp & Dohme LLC · US

Inventors

Martin Oft · Palo Alto, US
Catherine Sheppard · San Francisco, US
John Brian Mumm · Bethesda, US
Lingling Wu · Nanning, CN

Key dates

Filing date	May 16, 2016
Grant date	Dec 5, 2017
Priority date	—
Expiry date	May 16, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are methods of treatment for tumors. In particular, methods are provided for use of a chemically modified IL-10 to treat tumors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.